Main Menu
About
万博下载手机客户端
Amgen History
Mission and Values
领导
Awards and Accolades
How We Operate
万博下载手机客户端
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
万博下载手机客户端
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
万博下载手机客户端
About Clinical Trails
Amgen Clinical Trails
Clinical Study Report Synopses
Clinical Trial Diversity
Lay Summary of Clinical Trail Result
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
2ManBetX登陆
2ManBetX登陆
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
万博下载手机客户端
Innovation
Quality
Reliability
PRODUCTS
万博下载手机客户端
Medical Information
333manbetx
Safety Data Sheets
Global Patient Safety
万博下载手机客户端
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
max万博体育
万博下载手机客户端
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
万博下载手机客户端
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches, and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
万博下载手机客户端
About the Amgen Foundation
Amgen Foundation Grants
Programs for Teachers
Programs for Students
About the Amgen Foundation
Commitment to Community
万博下载手机客户端
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients
Diversity, Inclusion and Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
万博下载手机客户端
Performance
2020 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
万博下载手机客户端
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
max万博体育
People and Culture
Science and Innovation
Patients
领导
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
服务Our Communities
Newsroom
mandetx网页登录
max万博客户端苹果
Careers
Amgen Worldwide
万博下载手机客户端
Research and Development Strategy
Pipeline
" menu-type="header" data-value="FLItem-4-SLItem-3">Overview
Scientific Advisory Boards
Amgen Science
" menu-type="header" data-value="FLItem-4-SLItem-5">Pipeline
Amgen Competitive Grants
Biosimilars
" menu-type="header" data-value="FLItem-4-SLItem-7">
Clinical Trials
2ManBetX登陆
Manufacturing
All Stories
max万博体育
People and Culture
Science and Innovation
Patients
领导
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
服务Our Communities
About
万博下载手机客户端
Amgen History
Mission and Values
领导
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
万博下载手机客户端
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Study Report (CSR) Synopses
Clinical Trial Diversity
Lay Summary of Clinical Trial Results
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
2ManBetX登陆
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
万博下载手机客户端
Medical Information
333manbetx
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
max万博体育
万博下载手机客户端
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2020 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
max万博体育
People and Culture
Science and Innovation
Patients
领导
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
服务Our Communities
Newsroom
mandetx网页登录
max万博客户端苹果
Careers
X
Home
>
Stories
>
Science and Innovation
>
Science and Innovation Stories
SCIENCE & INNOVATION
12.07.2020
Rapidly Advancing Development of Amgen’s Investigational KRAS
G12C
Inhibitor
A new approach to R&D boosts Amgen's speed and agility in product development.
Read more
All Stories
All
PATIENTS
max万博体育
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
max万博体育
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
SCIENCE & INNOVATION
12.07.2020
Rapidly Advancing Development of Amgen’s Investigational KRAS
G12C
Inhibitor
SCIENCE & INNOVATION
12.04.2020
咬
®
Technology 101: Learn the What, How, Who and Why of Amgen’s Innovative BiTE Immuno-Oncology Platform
SCIENCE & INNOVATION
11.03.2020
Why Do Up-and-Coming Scientists Join Amgen's Postdoc Program?
SCIENCE & INNOVATION
10.28.2020
Support for Breast Cancer Survivors, Including One on Our Team
SCIENCE & INNOVATION
10.19.2020
Applying the Power of Omics to R&D
SCIENCE & INNOVATION
10.06.2020
Undruggable Targets Meet Their Match in New Amgen Science Cartoon
SCIENCE & INNOVATION
09.28.2020
Amgen Hosts Live Fireside Chat on New Age of Multispecific Medicines
SCIENCE & INNOVATION
09.20.2020
Taking on
KRAS
SCIENCE & INNOVATION
09.18.2020
For People With Lung Cancer, Expanded Biomarker Testing Is Key to Advancing Science
SCIENCE & INNOVATION
09.11.2020
Amgen's Crystal Bone Algorithm May Help Identify Osteoporosis Fracture Risk
Load more
Loading...